Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul V O'Donnell

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Blood Reviews|November 26, 2022
The development of post-transplant cyclophosphamide: Half a century of translational team sciencePaul V O'Donnell, Richard J Jones
Current Opinion in Oncology|February 26, 2003
Nonmyeloablative alternative donor transplantsLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Seminars in Oncology|December 5, 2012
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Current Opinion in Oncology|February 7, 2013
Alternative transplant donor sources: is there any consensus?Ephraim Fuchs, Paul V O'Donnell, Claudio G Brunstein
NEJM Evidence|February 6, 2024
A 67-Year-Old Man with Pruritus and DyspneaJennifer Chen Li, Nicole A LaHood, Paul V O'Donnell, et al.
Seminars in Hematology|March 23, 2016
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamideTara M Robinson, Paul V O'Donnell, Ephraim J Fuchs, et al.
Cancer Chemotherapy and Pharmacology|August 3, 2013
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipientsMeagan J Bemer, Mohamed Sorror, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipientsMarilyn J Hammer, Corey Casper, Ted A Gooley, et al.
Journal of Comparative Effectiveness Research|March 21, 2014
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerJoshua A Roth, Mark E Bensink, Paul V O'Donnell, et al.
Journal of Clinical Pharmacology|January 16, 2010
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administrationDavid H Salinger, Paolo Vicini, David K Blough, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Blood Reviews|November 26, 2022
The development of post-transplant cyclophosphamide: Half a century of translational team sciencePaul V O'Donnell, Richard J Jones
Current Opinion in Oncology|February 26, 2003
Nonmyeloablative alternative donor transplantsLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Seminars in Oncology|December 5, 2012
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Current Opinion in Oncology|February 7, 2013
Alternative transplant donor sources: is there any consensus?Ephraim Fuchs, Paul V O'Donnell, Claudio G Brunstein
NEJM Evidence|February 6, 2024
A 67-Year-Old Man with Pruritus and DyspneaJennifer Chen Li, Nicole A LaHood, Paul V O'Donnell, et al.
Seminars in Hematology|March 23, 2016
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamideTara M Robinson, Paul V O'Donnell, Ephraim J Fuchs, et al.
Cancer Chemotherapy and Pharmacology|August 3, 2013
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipientsMeagan J Bemer, Mohamed Sorror, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipientsMarilyn J Hammer, Corey Casper, Ted A Gooley, et al.
Journal of Comparative Effectiveness Research|March 21, 2014
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerJoshua A Roth, Mark E Bensink, Paul V O'Donnell, et al.
Journal of Clinical Pharmacology|January 16, 2010
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administrationDavid H Salinger, Paolo Vicini, David K Blough, et al.
Pageof 6